Overview
Chi-fai Ng practices in Kuala Lumpur, Malaysia. Ng is rated as an Experienced expert by MediFind in the treatment of Neuroendocrine Tumor. Their top areas of expertise are Prostate Cancer, Bladder Cancer, Enlarged Prostate (BPH), Lithotripsy, and Prostatectomy.
Their clinical research consists of co-authoring 239 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Neuroendocrine Tumor.
Locations
Kuala Lumpur, Malaysia
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
3 Clinical Trials
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- LithotripsyNg isDistinguished. Learn about Lithotripsy.
- Prostate CancerNg isDistinguished. Learn about Prostate Cancer.
- Advanced
- Bladder CancerNg isAdvanced. Learn about Bladder Cancer.
- Enlarged Prostate (BPH)
- Kidney StonesNg isAdvanced. Learn about Kidney Stones.
- Non-Muscle Invasive Bladder Cancer
- OrchiectomyNg isAdvanced. Learn about Orchiectomy.
- ProstatectomyNg isAdvanced. Learn about Prostatectomy.
- Experienced
- Abdominal Obesity Metabolic Syndrome
- Anal CancerNg isExperienced. Learn about Anal Cancer.
- Bladder Outlet Obstruction
- Bladder ReconstructionNg isExperienced. Learn about Bladder Reconstruction.
- Compartment SyndromeNg isExperienced. Learn about Compartment Syndrome.
- COVID-19Ng isExperienced. Learn about COVID-19.